Despite animal testing being a controversial topic for many years, it is still widely used globally to assess the safety of products and test the efficacy of new treatments and products. In 2020, the United States was the world’s largest user of animals in research and testing, with around 20 million animals used research and testing, followed by China where it is estimated that around 16 million animals were used in research and testing in that year. Animal testing is used especially in the medical, cosmetic, and chemical industries.

Animal Testing in the EU

The European Union also reported some 9.4 million animals used research and testing as of 2020. Basic research, and translational and applied research are the two leading purposes of animal testing in the European Union. Mice represent the most commonly used animal in research and testing in the EU, representing almost half of all animals used in research and testing, followed by fish and rats.

Animal Testing in Great Britain

Animal testing in Great Britain was most common in basic scientific research on the nervous system and the immune system, and most procedures on animals for scientific experiments in that year in Great Britain were conducted by universities and medical schools. As in the EU, mice were the most commonly used animals in research and testing, followed by domestic fowl and rats.

In 2019, 797,546 animals were used for research in research facilities in the United States. This is an increase from the previous year, when about 780,070 animals were used for research in the country.

This statistic shows the moral stance of Americans regarding medical testing on animals in 2018. During the survey, 54 percent of respondents stated that they think medical testing on animals is morally acceptable, while 2 percent said it depends.

This statistic displays the share of purposes for scientific research on animals in the 27 European Union countries (including Norway) in 2019. The main purpose for testing on animals was for basic research, with some 45 percent.

The provided information includes: year, month, animal species, purpose, vaccine name, code, brand category, brand name, batch number, total dose, expiry date, and judgment field data.

USDA 2016 Data on Animal Testing in the United States

Broken down by State / Territory

Required Reporting by Testing Facilities in the US

Each USDA-registered research facility and Federal research facility is required by the Animal Welfare Act (AWA) to submit an Annual Report (APHIS Form 7023) that documents its use of animals for research, testing, teaching, experimentation, and/or surgery. USDA-APHIS Animal Care receives copy of each research facility’s annual report on or before December 1. Animal Care reviews the data to ensure the calculated totals are consistent with the number of reported animals in each pain/distress category. Reports with inconsistent data are returned to the research facility for correction. The completeness and accuracy of the non-Federal research facility annual reports might be validated during USDA animal welfare compliance inspections. However, research facilities sometimes include additional data on their annual reports that is not required under the Animal Welfare Act, such as data about rats of the genus rattus, mice of the genus mus, and birds bred for use in research, animals used in excluded field studies, animals used in clinical trials in the context of a veterinary client relationship, and reptiles, fish, or other animals that are not covered by the AWA.

Summary

The data in the summary reports represent the number of animals USDA-registered research facilities and Federal research facilities reported as being used or held for research, testing, teaching, experimentation, and/or surgery. The summary reports are based on the Annual Report column designations:

• Column B (animals held by a facility but not used in any research that year).

• Column C (animals used in research; no pain involved; no pain drugs administered).

• Column D (animals used in research; pain involved; pain drugs administered).

• Column E (animals used in research; pain involved; no pain drugs administered).

• ALL_PAINTYPES_2016 = (total number of animals used in research; Column C + Column D + Column E).

States include 50 states plus Puerto Rico (PR) and District of Columbia (DC).

Acknowledgements

USDA Animal and Plant Health Inspection Service More years found here: https://www.aphis.usda.gov/aphis/ourfocus/animalwelfare/sa_obtain_research_facility_annual_report/ct_research_facility_annual_summary_reports

Inspiration

The Beagle Freedom Project (Photo taken from there website)

The Humane Society

Peta

Bruna, Chewy, Cat Stevens, Remy, Owen, Neumann and Timmy (dogs and one cat).

This statistic displays the total number of animals used in scientific research in the European Union from 2015 to 2022, including only animals used for the first time each year. In 2022, some 8.4 million animals were used in scientific research in all EU member states and Norway, an increase of over 400 thousand compared to the previous year.

Research Animals

## Overview

Research Animals is a dataset for classification tasks - it contains Extintos NaoExtintos annotations for 1,918 images.

## Getting Started

You can download this dataset for use within your own projects, or fork it into a workspace on Roboflow to create your own model.

  ## License

  This dataset is available under the [CC BY 4.0 license](https://creativecommons.org/licenses/CC BY 4.0).

Background: The harm benefit analysis (HBA) is the cornerstone of animal research regulation and is considered to be a key ethical safeguard for animals. The HBA involves weighing the anticipated benefits of animal research against its predicted harms to animals but there are doubts about how objective and accountable this process is.

Objectives: i. To explore the harms to animals involved in pre-clinical animal studies and to assess these against the benefits for humans accruing from these studies; ii. To test the feasibility of conducting this type of retrospective HBA.

Methods: Data on harms were systematically extracted from a sample of pre-clinical animal studies whose clinical relevance had already been investigated by comparing systematic reviews of the animal studies with systematic reviews of human studies for the same interventions (antifibrinolytics for haemorrhage, bisphosphonates for osteoporosis, corticosteroids for brain injury, Tirilazad for stroke, antenatal cort...

The global animal research and testing market is projected to reach a market size of USD XXX million by 2033, growing at a CAGR of XX% from 2023 to 2033. Key drivers of this growth include the rising prevalence of chronic diseases, the need for more accurate and reliable preclinical data, and the growing adoption of animal models in biomedical research. Additionally, the increasing demand for personalized medicine and the growing investment in drug discovery and development are expected to drive the market growth over the forecast period. Key trends in the animal research and testing market include the increasing adoption of genetically modified animal models, the adoption of non-animal models, and the use of artificial intelligence (AI) and machine learning (ML) to enhance research and testing processes. The growing focus on animal welfare and the ethical concerns associated with animal testing are also restraining the market growth. However, the increasing adoption of alternative methods, such as in vitro and in silico models, is expected to alleviate these concerns and drive the market growth. North America is the largest regional market for animal research and testing, followed by Europe and Asia Pacific. Asia Pacific is expected to experience the highest growth rate due to the increasing demand for animal models in biomedical research and the growing investment in drug discovery and development in the region.

The objective of this study was to evaluate the safety and immunogenicity of a live, attenuated recombinant RVF arMP-12ΔNSm21/384 nucleotide deletion vaccine candidate in domestic ruminants. . The immunogenicity of 2 doses of 104 and 105 Tissue Culture Infectious Doses50% (TCID50) of the vaccine was assessed in of 2 groups of 10 sheep, 2 groups of 10 goats, and doses of 105 and 106 TCID50 were used to vaccinate 2 groups of 10 calves. The results showed that the immunogenicity among sheep, goats and cattle indicated that doses of 104 - 106 TCID50 elicited detectable antibody by day 7 post-vaccination and antibody titers that ranged from 1:14 to 1:305 on day 14 PV with sustained titers through day 28 PV. Overall, these findings indicated that the RVF arMP-12ΔNSm21/384 vaccine is a promising candidate for the prevention of RVF among domestic ruminants.

BackgroundDiskDataCircleGetRGBcombinationsIshiharaoidAndStimuliReadParamsIshiharaoidDiskGenerationIshiParametersAchromaticMakeStimuliOnGrayBackgroundReadme

Abstract Integrity in animal research, coupled with scientific and social responsibility, demands rigor in the construction and execution of the protocol, commitment to the promotion of animal welfare and the dissemination of suitable data. Protocols for submitting projects to the Ethics Committee on Animal Use, editorial policies and dissemination of the methodology as tools to promote research integrity were analysed based on the questioning of the vulnerability of researchers not trained to fulfill this demand. The results supported the insertion of planning and dissemination of research as a parameter of integrity and adherence to the principle of 3R (Replacement, Reduction and Refinement) as a guide to the decision of how much and how and why to use animals in research. We verified the efficiency of the administrative and legal instrument as a promoter of reflection on technical, ethical, social and legal conception and society. These should be subsidized by the educational role of Bioethics, carried out by committees to mitigate vulnerabilities of the researcher.

Animals at petting zoos and agricultural fairs can be carriers of pathogens, such as Escherichia coli. Disease outbreaks at animal contact exhibits can be prevented by handwashing after contact with animals and keeping food and beverage away from exhibits. This research procedure and code book accompanies the data set, Animal Contact Exhibits_Legal Epidemiology Dataset_2016, which catalogs and analyzes a collection of state hand sanitation laws for the following categories of animal contact exhibits: a. Petting zoos b. Agricultural fairs c. County or state fairs d. Exotic animal exhibits e. Circuses f. Zoos

Snapshot img

Preclinical Animal Telemetry Market 2024-2028

The global preclinical animal telemetry market size is estimated to grow by USD 21.55 million at a CAGR of 5.69% between 2023 and 2028.

As a part of organic growth strategies, companies are increasingly focusing on new feature integration, as well as product development and launches. The launch of new products is allowing companies to remain competitive in the market by offering the latest available technologies to their customers. Additionally, companies can efficiently meet the specific demands of end-users by bringing innovative changes in their product lineup as per customers' expectations. Some of the recent product launches have been discussed below: Since 2021, the US Animal Telemetry Network (ATN) has been attempting to integrate ocean profiles obtained from animal-borne satellite telemetry tags, including the Wildlife Computers SCOUT-CTD, into the World Meteorological Organizations Global Telecommunication System. Such constant improvements and upgrades in features have brought significant differentiation in products and have helped companies lower the competition and increase product penetration. Therefore, an increase in product launches of preclinical animal telemetry is driving the market growth during the forecast period.

Technavio has segmented the market into End-user, Type, and Geography

The end-user segment is classified into industrial laboratories and CROs, academic government, and other research laboratories
The type segment is classified into small animal telemetry and large animal telemetry
The geography segment includes key regions such as North America, Europe, Asia, and Rest of World (ROW)

It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historical data from 2018-2022, besides analyzing the current market scenario.

What will be the Size of the Preclinical Animal Telemetry Market During the Forecast Period?

To learn more about this report, Download Report Sample

Preclinical Animal Telemetry Market Segmentation by End-user, Type and Geography Analysis

End-user Analysis

Industrial laboratories and CROs

The market share growth by the industrial laboratories and CROs segment will be significant during the forecast period. Industrial laboratories (including pharmaceutical and biotechnology companies) and CROs are among the key organizations involved in drug discovery, research, design, and development. These organizations spend a considerable number of resources and time in preclinical and clinical research for advancing new therapeutic candidates.

Get a glance at the market contribution of various segments Download PDF Sample

The Industrial laboratories and CROs were the largest segment and were valued at USD 32.41 million in 2018. Further, the increase in patent expiries of blockbuster drugs and biologicals has led to an increased focus on R&D activities. As a result, pharmaceutical and biotechnology companies are increasingly promoting the outsourcing of clinical research to CROs. This led to the outsourcing of R&D activities for developing new formulations. To reduce the risk of adverse events during clinical trials of these new formulations, the demand for preclinical animal testing, including toxicology testing and cosmetic testing, has increased. Animal telemetry solutions are finding extensive use for collecting and analyzing a large amount of preclinical safety and efficacy data. This preclinical safety and efficacy data is required to be submitted to drug regulatory authorities before permission for further studies in humans is granted. As a result, significant demand for preclinical animal research and testing can be observed across industrial laboratories and CROs globally, which is driving the adoption of animal telemetry systems, which, in turn, will drive the growth of the market during the forecast period.

Type Analysis

Small animal telemetry

The small animal telemetry segment includes animal telemetry solutions that are used in preclinical research with small animals such as mice, rabbits, ferrets, rats, hamsters, and Guinea pigs. Small animal telemetry solutions are usually miniaturized telemetry implants that are small in size and lightweight and can be custom-configured and modified as per the research and testing requirements. Furthermore, the availability of cost-effective, minimally invasive, wireless battery charging-based, flexible telemetry systems is adding to the growing sales of small animal telemetry systems. The market is expected to witness swift growth owing to stringencies in regulations for maintaining pharmacological safety and the growing availability of funding for research related to neuroscience, cardiology, and oncology.

Regional Analysis

For more insights about the market share of various regions Download PDF Sample now!

North America is estimate

Annual Statistics collected relating to Scientifiic procedures performed on living animals under the provisions of the Animals (Scientific Procedures) Act 1986, from licenses in accordance with section 21(7) of the Act.

Source agency: Home Office

Designation: National Statistics

Language: English

Alternative title: Scientific Procedures on Living Animals

Recent USDA/ARS patented technologies on animal production and protection that are available for licensing are described, including summary, contact, benefits, and applications. Updated June 2018. Resources in this dataset:Resource Title: Animal Production and Protection - Available Technologies, June 2018. File Name: Animal Production and Protection.pptxResource Description: Slides presenting title, contact, docket number(s), description, image, benefits, and applications of each new technology.Resource Title: Patented Technologies Data Dictionary. File Name: patented-technologies-data-dictionary.csvResource Description: Defines fields, data type, allowed values etc. in patented technology tables.Resource Title: Animal Production & Protection - June 2018. File Name: Animal_Production_and_Protection_2018-06.csvResource Description: Listing of technologies to improve the health, well-being, and efficiency of livestock, poultry, and aquatic food animals to ensure a productive and safe food supply. This CSV file provides the title, technology type, docket number, contact, description, and category for each item. Machine-readable content extracted from corresponding slides accompanying this dataset.

This statistic shows how likely consumers in the United States would be to stop purchasing from their favorite cosmetics/makeup brand if it were reported that they test their products on animals as of April 2017, by gender. During the survey, ** percent of female consumers reported that they would very likely stop purchasing from their favorite brand if they tested on animals, compared with ** percent of male respondents.